Novartis Investigative Site

Köseköy, Kocaeli 41380

2 studies enrolling now · 5 studies all time

What they study most

C3 Glomerulopathy, IC-MPGN, IgA Nephropathy, Immune-complex-membranoproliferative Glomerulonephritis, Myelodysplastic Syndromes, Primary IgA Nephropathy

Studies at this site

• Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN — Recruiting now
• Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN — Recruiting now
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy — Running, not enrolling
• A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). — Stopped early
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed